Drug Abuse Sciences
Menlo Park
About Drug Abuse Sciences
Drug Abuse Sciences develops and commercializes therapies for the treatment of alcohol and drug addictions. It offers Naltrexone Depot, a sustained-release formulation of Naltrexone for the treatment of alcohol and opiate addictions; DAS-431 for the treatment of cocaine addiction; and Buprenorphine Depot, a sustained-release formulation of buprenorphine for the treatment of heroin and various opiate addictions. Drug Abuse Sciences is based in Menlo Park, California.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Total funding: $98.1M
- Last round: Series Unknown (Jul 2007)
- Website: drugabusesciences.com
Industries & Categories
Biotechnology, Health Care, Medical
Canonical: https://fsome.com/organization/drug-abuse-sciences-3014795 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.